Berkow R, Beers MH, Burs M, eds.
The Merck Manual. 17th ed. West Point, PA: Merck & Co; 1999.
Bolognia JL, Jorizzo J, Rapini RP.
Dermatology. London: Elsevier Science; 2003.
Chung L, Genovese MC, Fiorentino DF. A pilot trial of rituximab in the treatment of patients with dermatomyositis.
Dalakas MC. Polymyositis, dermatomyositis, and inclusion body myositis. In: Kasper DL, et al, eds.
Harrison's Principles of Internal Medicine. 16th ed. New York: McGraw-Hill; 2005: 2540-2545.
Dermatomyositis. EBSCO Dynamed website. Available at:
http://www.ebscohost.com/dynamed/what.php. Accessed August 2005.
Dold S, Justiniano ME, Marquez J, Espinoza LR. Treatment of early and refractory dermatomyositis with infliximab: a report of two cases.
Wong EH, Hui AC, Griffith JF, et al. MRI in biopsy-negative dermatomyositis.
Please be aware that this information is provided to supplement the care
provided by your physician. It is neither intended nor implied to be a
substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER
IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the
advice of your physician or other qualified health provider prior to
starting any new treatment or with any questions you may have regarding a
Copyright © 2007
EBSCO Publishing All rights reserved.